Back to top
more

GE HealthCare Technologies Inc. (GEHC)

(Real Time Quote from BATS)

$70.87 USD

70.87
217,700

+0.23 (0.33%)

Updated Aug 5, 2025 10:26 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

1-Strong Buy of 5 1        

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value F Growth A Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 37% (155 out of 246)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Stock Market News for Feb 7, 2024

by Zacks Equity Research

U.S. stock markets higher on Tuesday after a sharp fall on Monday.

Zacks Equity Research

GE HealthCare (GEHC) Q4 Earnings Beat, Volume & Price Improve

by Zacks Equity Research

GE HealthCare's (GEHC) fourth-quarter results benefit from continued demand for imaging, patient care and pharmaceutical diagnostic solutions. Sales gain from improved pricing.

Zacks Equity Research

GE HealthCare (GEHC) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

by Zacks Equity Research

While the top- and bottom-line numbers for GE HealthCare (GEHC) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zacks Equity Research

GE HealthCare Technologies (GEHC) Q4 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

GE HealthCare (GEHC) delivered earnings and revenue surprises of 10.28% and 2.21%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

GE HealthCare (GEHC) to Report Q4 Earnings: What's in Store?

by Zacks Equity Research

GE HealthCare (GEHC) is expected to report strong organic revenue growth, banking on balanced segmental performance, driven by consistent NPIs and growing customer demand.

Zacks Equity Research

GE Healthcare (GEHC) Buys MIM Software to Boost Imaging Tools

by Zacks Equity Research

GE Healthcare (GEHC) is likely to enhance medical imaging capabilities and boost powerful AI solutions with the acquisition of MIM Software. Financial details are kept under cover.

Zacks Equity Research

Is SPDR S&P Health Care Equipment ETF (XHE) a Strong ETF Right Now?

by Zacks Equity Research

Smart Beta ETF report for XHE

Zacks Equity Research

The Zacks Analyst Blog Highlights DaVita, GE HealthCare Technologies and Hologic

by Zacks Equity Research

DaVita, GE HealthCare Technologies and Hologic are part of the Zacks top Analyst Blog.

Debanjana Dey headshot

3 Beaten-Down MedTech Stocks Poised for a Turnaround in 2024

by Debanjana Dey

Here are some dirt-cheap MedTech value stocks - DVA, GEHC, HOLX - which are expected to provide long-term gains.

Indrajit Bandyopadhyay headshot

3 MedTech Stocks With Potential to Benefit From AI Boom in 2024

by Indrajit Bandyopadhyay

Investors looking to tap the budding prospects in the lucrative AI market in 2024 can count on Medtronic (MDT), GE HealthCare Technologies (GEHC) and Hologic (HOLX).

Zacks Equity Research

Should You Invest in the SPDR S&P Health Care Equipment ETF (XHE)?

by Zacks Equity Research

Sector ETF report for XHE

Zacks Equity Research

GE HealthCare Technologies (GEHC) Crossed Above the 200-Day Moving Average: What That Means for Investors

by Zacks Equity Research

Should investors be excited or worried when a stock crosses above the 200-day simple moving average?

Zacks Equity Research

Masimo's (MASI) Latest Tie-Up to Boost Patient Monitoring

by Zacks Equity Research

Masimo's (MASI) latest joint effort is likely to enable real-time continuous monitoring with a tailored view of the patient's vitals while keeping them mobile during critical recovery periods.

Zacks Equity Research

Is SPDR S&P Health Care Equipment ETF (XHE) a Strong ETF Right Now?

by Zacks Equity Research

Smart Beta ETF report for XHE

Zacks Equity Research

GE HealthCare (GEHC) to Report Q3 Earnings: What's in Store?

by Zacks Equity Research

GE HealthCare (GEHC) is expected to report strong organic revenue growth, banking on balanced segmental performance driven by consistent NPIs and growing customer demand.

Zacks Equity Research

Should You Invest in the SPDR S&P Health Care Equipment ETF (XHE)?

by Zacks Equity Research

Sector ETF report for XHE

Zacks Equity Research

Stock Market News for Sep 26, 2023

by Zacks Equity Research

U.S. stock markets closed higher on Monday to start the last week of a highly volatile September.

Zacks Equity Research

GEHC or PRVA: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

GEHC vs. PRVA: Which Stock Is the Better Value Option?

Zacks Equity Research

GEHC or PRVA: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

GEHC vs. PRVA: Which Stock Is the Better Value Option?

Zacks Equity Research

GEHC or PRVA: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

GEHC vs. PRVA: Which Stock Is the Better Value Option?

Zacks Equity Research

GE HealthCare (GEHC) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

by Zacks Equity Research

GE HealthCare (GEHC) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.

Zacks Equity Research

GEHC vs. PRVA: Which Stock Is the Better Value Option?

by Zacks Equity Research

GEHC vs. PRVA: Which Stock Is the Better Value Option?

Zacks Equity Research

GE HealthCare (GEHC) to Report Q2 Earnings: What's in Store?

by Zacks Equity Research

GE HealthCare's (GEHC) Imaging revenue growth in Q2 is expected to have been led by Magnetic Resonance as well as its molecular imaging entity.

Zacks Equity Research

The Zacks Analyst Blog Highlights InMode, Johnson & Johnson, Intuitive Surgical and GE HealthCare

by Zacks Equity Research

InMode, Johnson & Johnson, Intuitive Surgical and GE HealthCare are included in this Analyst Blog.

Indrajit Bandyopadhyay headshot

Solid Earnings Fuel Potential Bull Market in Medical Devices

by Indrajit Bandyopadhyay

CNBC's Jim Cramer predicts a booming bull market for medical devices, with positive earnings reports across the space. INMD, JNJ, ISRG and GEHC can emerge as potential winners.